These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 1981555)
1. Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Perrault G; Morel E; Sanger DJ; Zivkovic B Eur J Pharmacol; 1990 Oct; 187(3):487-94. PubMed ID: 1981555 [TBL] [Abstract][Full Text] [Related]
2. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178 [TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone. Byrnes JJ; Greenblatt DJ; Miller LG Brain Res Bull; 1992 Dec; 29(6):905-8. PubMed ID: 1361878 [TBL] [Abstract][Full Text] [Related]
4. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent]. Shirakawa K Nihon Yakurigaku Zasshi; 2002 Feb; 119(2):111-8. PubMed ID: 11862759 [TBL] [Abstract][Full Text] [Related]
6. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents. Griebel G; Perrault G; Sanger DJ J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909 [TBL] [Abstract][Full Text] [Related]
7. The effects of new hypnotic drugs in rats trained to discriminate ethanol. Sanger DJ Behav Pharmacol; 1997 Aug; 8(4):287-92. PubMed ID: 9832988 [TBL] [Abstract][Full Text] [Related]
8. Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors. Sanger DJ; Zivkovic B Neuropharmacology; 1992 Jul; 31(7):693-700. PubMed ID: 1357576 [TBL] [Abstract][Full Text] [Related]
9. [A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]. Benavides J; Depoortere H; Sanger D; Perrault G; Arbilla S; Langer SZ; Zivkovic B; Scatton B Encephale; 1990; 16(1):13-22. PubMed ID: 2158421 [TBL] [Abstract][Full Text] [Related]
10. The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats. Yoshimoto M; Higuchi H; Kamata M; Yoshida K; Shimizu T; Hishikawa Y Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):29-35. PubMed ID: 10082225 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the hypnotic zolpidem in vivo. Crestani F; Martin JR; Möhler H; Rudolph U Br J Pharmacol; 2000 Dec; 131(7):1251-4. PubMed ID: 11090095 [TBL] [Abstract][Full Text] [Related]
12. Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867A, or Ro23-0364, in the rat. Yerbury RE; Cooper SJ Pharmacol Biochem Behav; 1989 Jun; 33(2):303-7. PubMed ID: 2573076 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes]. Yasui M; Kato A; Kanemasa T; Murata S; Nishitomi K; Koike K; Tai N; Shinohara S; Tokomura M; Horiuchi M; Abe K Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):143-51. PubMed ID: 16045197 [TBL] [Abstract][Full Text] [Related]
15. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. Sanger DJ CNS Drugs; 2004; 18 Suppl 1():9-15; discussion 41, 43-5. PubMed ID: 15291009 [TBL] [Abstract][Full Text] [Related]
16. Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice. Heldt SA; Ressler KJ J Neurosci; 2010 May; 30(21):7139-51. PubMed ID: 20505082 [TBL] [Abstract][Full Text] [Related]
17. Differences in enhancing effects of zolpidem and benzodiazepine drugs on recurrent inhibition in rat hippocampal slices. Higashima M; Kinoshita H; Yamaguchi N; Koshino Y Psychopharmacology (Berl); 1997 Jun; 131(4):394-8. PubMed ID: 9226742 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. Benavides J; Peny B; Durand A; Arbilla S; Scatton B J Pharmacol Exp Ther; 1992 Nov; 263(2):884-96. PubMed ID: 1331419 [TBL] [Abstract][Full Text] [Related]
19. Specificity within the GABAA receptor supramolecular complex: a consideration of the new omega 1-receptor selective imidazopyridine hypnotic zolpidem. Lloyd KG; Zivkovic B Pharmacol Biochem Behav; 1988 Apr; 29(4):781-3. PubMed ID: 2842810 [TBL] [Abstract][Full Text] [Related]
20. [Contribution of zolpidem in the management of sleep disorders]. Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P Encephale; 1992; 18(4):379-92. PubMed ID: 1363657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]